Specializes in: Government, science and medicine, health policy, epidemiology, investigative journalism
An award-winning investigative journalist, Bryant's reporting has appeared in New Scientist, The Lancet Oncology, the European Cancer Journal, The Guardian, New Mexico Business Weekly and more than a dozen other publications around the world.
Bryant's reporting on health insurance giant UnitedHealth's acquisition of the Lewin Group, a leading health policy consulting firm that advises congress, won praise from the Columbia Journalism Review's Election Desk.
Covering Northern New Mexico for the Rio Grande Sun, Bryant exposed election law violations, the impact of hospital budget cuts on ambulance response times and the off-label use of psychiatric drugs to sedate jail inmates — a practice that led to the emergence of Seroquel as a street drug. The Seroquel series won a first place award for investigative reporting at the New Mexico Press Association/AP 2009 conference.
Bryant's reporting on U.S. Army censorship of health research at Walter Reed and elsewhere was spotlighted by ProPublica, the AAAS Scientific Freedom, Responsibility & Law Program, the National Coalition Against Censorship and the Federation of American Scientists'
Bryant also broke the story, subsequently reported by the New York Times and UPI, of the Veterans Administration's failure to report more than 100,000 cancer cases to the tumor registries used to track veterans' cancer rates.
Bryant graduated with top honors in biology from the University of New Mexico and studied international relations at California State University, Sacramento.
His scholarly research has been published in several peer-reviewed journals, including the Proceedings of the Royal Society of London, and has been reviewed in the journal Nature.
Last updated: 10/18/2016 ()